ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
OneSource Specialty Pharma reported strong Q1FY27 results, with revenue growing 37% YoY and EBITDA increasing 39% YoY, driven by semaglutide commercialization and new customer wins.
OneSource reported FY26 revenue of ₹1,421.60 Crore with strong Q4 recovery. Management reaffirmed its FY28 guidance of $400 million organic revenue.